DOCSLIB.ORG

June 2018 Newsletter

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
June 2018 Newsletter NEWSLETTER June 2018 to advance education and research in the science of www.bap.org.uk psychopharmacology for the public benefit INSIDE 1–2 2018 Lifetime Achievement Award 2–7 2018 BAP Elections 7 BAP in vivo Animal Research Funding 8 BAP Psychopharmacology Awards 2018; NEW POST – BAP Assistant Director of Education 9–10 15th Computational Systems Neuroscience Conference (COSYNE), Denver 11–13 Updated Privacy Policy 13 2018 AGM Agenda 14–16 BAP Summer Meeting 2018 17 REF2021 Success; Members’ Activities 18–23 Street Drugs in the Northern Powerhouse: Perspective and Policy 23 Substance Misuse Module 24 The MRC Addiction Research Clinical Training scheme (MARC) 25–27 Education Events 2018 Lifetime Achievement Award Professor Guy Goodwin We are delighted to announce that the 2018 Lifetime Achievement Award will be presented to Professor Guy Goodwin at the Conference Dinner at the Royal British Association for Garden Hotel in Kensington on Tuesday 24 July. Psychopharmacology Guy is internationally renowned in psycho- pharmacology and his work has had a profound 36 Cambridge Place impact on both basic and clinical research particularly Hills Road in the areas of depression and bipolar disorder. Cambridge CB2 1NS Guy graduated with a 1st Class Honours degree in 01223 358 395 Animal Physiology from the University of Oxford in 1968 and completed a DPhil in Neurophysiology at Executive Officer Susan Chandler • [email protected] Oxford in 1972. His doctoral thesis included seminal work on mechanisms of kinaesthesia, the control of Assistant to the Executive Officer Lynne Harmer • [email protected] isometric contraction by muscle afferents and the role of the central command to exercise in the regulation Online Resources and Communications Developer of the cardiovascular and respiratory systems which Sarah Channing-Wright • [email protected] was published in highly cited papers in “Science” and “Brain”. Following a two year period of post-doctoral For m @BAPsych research at the Primate Centre of the University of Washington in Seattle, Guy returned to medical BritishAssociationforPsychopharmacology continued on page 2 /company/britishassociationforpsychopharmacology The British Association for Psychopharmacology is registered in England +BapOrgUk as a Private Company No 5866899. Registered Charity No 277825. continued from page 1 that correlated with memory impairment. This has supported a shift in drug development towards an training at Oxford and graduated in medicine in interest in neurogenesis as a mechanism underlying 1978. Further general clinical training and training the action of effective antidepressants and cognition as in psychiatry in Oxford and London from 1978-1983 a target for remediation in depression. Guy continues preceded Guy’s appointment as an MRC Clinical to break new ground in experimental medicine studies Training Fellow at the MRC Clinical Pharmacology and treatment trials in psychiatry and has been a Unit in the Radcliffe Infirmary in Oxford in 1983. lead investigator in clinical trials for bipolar affective Working with Richard Green and David Graeme- disorder, including the BALANCE, CEQUEL and Smith, Guy conducted a biochemical and behavioural OXTEXT studies. Guy has contributed to the systematic analysis of serotonin function at novel 5-HT receptors review of most of the important drug treatments for in the brain and how these actions are modified by bipolar disorder and in collaboration wrote widely cited antidepressants and lithium. This work has had a guidelines supporting evidence-based treatment. significant and enduring impact on the search for novel antidepressants. Subsequently, in 1986 Guy National and International recognition of Guy’s took up the position of MRC Clinical Scientist and talents is evidenced by his election as a Fellow of the Honorary Consultant Psychiatrist at the University American College of Neuropsychopharmacology of Edinburgh and in 1995 became Professor of and as a Fellow of the Academy of Medical Sciences Psychiatry. After 10 years “north of the border “ in addition to numerous prestigious awards and Guy returned to Oxford in 1996 to become the W.A. prizes in Psychopharmacology. Guy is also currently Handley Professor and Head of the Department of the Past-President of the European College of Psychiatry at the Warneford Hospital for the next Neuropsychopharmacology. Guy has been a driving 15 years. He retired from the university earlier this force in the BAP for more than 25 years, first year, to be free to take on new professional interests being elected as a member of Council in 1993 and which include the re-medicalization of psilocybin subsequently becoming President from 2002 to 2004. and improving how mood disorders are currently Guy has been and continues to be a regular attendee treated in primary and secondary care. and contributor to BAP meetings and BAP guidelines and is a longstanding member of the Editorial Board Over the past 35 years Guy has significantly impacted of the Journal of Psychopharmacology. Warmest research and clinical practice in the areas of bipolar congratulations to Guy on behalf of the BAP Council. disorder and depression and has conducted innovative clinical studies that often combine cognitive testing Colin Dourish and neuroimaging. In particular, Guy initiated studies of the processing of facial expressions of emotion and memory which have transformed our understanding 2018 Election for BAP Officers of how antidepressants work at a psychological level. This work has facilitated the discovery of novel and Council Members antidepressants and led to the development of an The following vacancies will arise on BAP Council in innovative method to rapidly identify the optimal July: antidepressant therapy for individual patients being treated for depression in primary care. Guy’s President-elect contributions to British psychopharmacology are Professor Allan Young will become President many and varied and he has trained numerous talented clinicians and scientists many of whom have gone on Two Elected Council Member posts to have very successful careers in their own right. (Post 3) Professor Carmine Pariante will retire Guy has published more than 500 papers with an h index of over 100. Of particular significance is his discovery of (Post 4) Dr Rachel Upthegrove has held this post as a the functional and structural brain changes associated casual vacancy since 2016 with severe depression. The findings in chronic One nomination was received for the post of depression showed a loss of tissue in hippocampus President Elect, so Professor Kevin Fone will be elected unopposed. Read Kevin’s statement below. 2 June 2018 Voting is online via the website only and will close Council Meetings: on MONDAY 2 JULY. The results will be announced at the Annual General Meeting on Monday 23 July in Three each year: March (London, 10:30–15:30), July London, in association with the Summer Meeting at (Sunday morning in association with the Summer Imperial College. Meeting), October/November (London, 10:30–15:30). The BAP aims to represent the interests of all Expenses: psychopharmacologists. Council asks Members to bear Council Members do not receive payment for this in mind when voting, to ensure a balance of expertise. anything they do for the BAP. BAP will reimburse Please refer to the BAP Equality and Diversity Statement standard travel expenses and hotel accommodation www.bap.org.uk/equality.php if Council members are unable to cover these from Council Members serve a 4-year term. an alternative source. Current Officers and Council See website for biographies www.bap.org.uk/council ELECTED OFFICERS ELECTED COUNCIL MEMBERS Professor Jo Neill Dr Michael Browning (Post 1) President Dr Tom Freeman Professor Allan Young (Post 2) President-Elect Dr Carmine Pariante (Post 3) Professor Paul Harrison Dr Rachel Upthegrove Past-President (Post 4) (filling a casual vacancy until July 2018) Dr Elizabeth Tunbridge Professor Ciara McCabe Honorary Treasurer (Post 5) Vacant until July 2019 due to Dr Talbot Dr Mitul Mehta moving to General Secretary post Meetings Secretary (Post 6) Dr Paul Stokes Dr Peter Talbot (Post 7) Honorary General Secretary Dr Angela Roberts Professor Jeremy Hall (Post 8) Secretary for Clinical External Affairs OTHER VOTING MEMBERS OF COUNCIL Dr Sarah Bailey Secretary for Non-Clinical External Affairs Jonas Eberhard June 2018 3 Candidates’ Biographies and Statements Kevin Fone Kevin has been extremely fortunate and grateful to have received collaborative funding from an array of University of Nottingham pharmaceutical companies and Research Councils. Proposer: Professor David Nutt He has published over 130 peer-reviewed articles, Seconder: Professor Nicol Ferrier supervised 40 postgraduate students, served on several editorial boards, is a Fellow of the British Kevin Fone has Pharmacological Society and currently President of been Professor of the International Society for Serotonin Research. Neuroscience in the School of Life Sciences at the University of Michael Bloomfield Nottingham since University College London 2006. He completed his BSc and PhD in Proposer: Professor Oliver Howes Pharmacology at Seconder: Professor Val Curran the University of I have recently been Liverpool before starting an MRC funded post- appointed as a UCL doctoral research position in Nottingham, where Excellence Fellow he has remained since 1984 and helped establish and will be working a successful Neuroscience undergraduate degree. clinically with His research focus has been
Load more

Recommended publications
  • Computational Psychiatry: Combining Multiple Levels of Analysis to Understand Brain Disorders
    Computational Psychiatry: Combining multiple levels of analysis to understand brain disorders. by Thomas Viktor Wiecki Diploma, University of T¨ubingen, January 2010 M. Sc., Brown University, May 2012 A Dissertation submitted in partial fulfillment of the requirements for the Degree of Doctor of Philosophy in the Cognitive, Linguistic & Psychological Sciences at Brown University Providence, Rhode Island May 2015 Copyright 2015 by Thomas Viktor Wiecki This dissertation by Thomas Viktor Wiecki is accepted in its present form by the Cognitive, Linguistic & Psychological Sciences as satisfying the dissertation requirement for the degree of Doctor of Philosophy. Date 9/23/2014 Michael J. Frank, Director Recommended to the Graduate Council Date Thomas Serre, Reader Date 9/24/2014 Erik Sudderth, Reader 9-25-14 Date Benjamin Greenberg, Reader Approved by the Graduate Council Date Peter M. Weber, Dean of the Graduate School iii Acknowledgements This dissertation would not have been possible without the support of many people and institutions throughout the last several years. First and foremost I am grateful to my supervisor and friend Michael J Frank who contributed to my development as a researcher in a major way. I am also thankful to the other members of my thesis committee – Thomas Serre, Erik Sudderth and Ben Greenberg – for thoughtful feedback. Daniel Dillon, as well as Sara Tabrizi, Chrystalina Antoniades, Chris Kennard, Beth Borowsky, Monica Lewis, and Mina Creathorn deserve my gratitude for generously sharing their clinical data with me and helpful discussions. In addition, I am grateful to the members of the Frank Lab and fellow grad stu- dents and faculty at Brown.
    [Show full text]
  • Mood and Cerebral Perfusion Revisited
    87 Mood and cerebral perfusion revisited Klaus P. Ebmeier studies or symptom provocation with tryptophan de- University Department of Psychiatry, Royal pletion, where deterioration in clinical state can be pre- Edinburgh Hospital, Morningside Park, Edinburgh, dicted [5,20,31]. Prospective single-scan designs have EH10 5HF, UK been used, trying to validate pre-treatment brain activ- ity maps by treatment response or outcome measure- ments [28]. While such longitudinal studies are an im- Twenty patients with major depression and observed diurnal provement on simple cross-sectional association stud- variations of mood were examined using clinical and neu- ies, their main disadvantage is that effects are based ropsychological measures and perfusion HMPAO-SPECT at on comparison between-subjects, which in selected 8 a.m. and 8 p.m. In thirteen patients depression scores varied samples of depressed patients are liable to confound- more than 15% between both measures, although 4 patients ing with other spurious differences of the compared with reverse diurnal variation caused mean group depres- groups. Mood induction experiments can be conducted sion scores to be not different between morning and evening. There was an overall trend for higher depression scores to be in healthy volunteers with due control of possible order associated with higher perfusion in posterior cingulate. This effects. Although the logical step from induced mood was mainly accounted for by significant positive correlations in healthy volunteers to mood changes in affective dis- in the morning scan in posterior, but also anterior cingulate orders may appear tenuous, remarkable similarities in and medial prefrontal cortex compared with evening scans.
    [Show full text]
  • European Network of Bipolar Research Expert Centre
    European Network of Bipolar Research Expert Centre (ENBREC): a network to foster research and promote innovative care Chantal Henry, Ole Andreassen, Angelo Barbato, Jacques Demotes-Mainard, Guy Goodwin, Marion Leboyer, Eduard Vieta, Willem Nolen, Lars Vedel Kessing, Jan Scott, et al. To cite this version: Chantal Henry, Ole Andreassen, Angelo Barbato, Jacques Demotes-Mainard, Guy Goodwin, et al.. European Network of Bipolar Research Expert Centre (ENBREC): a network to foster research and promote innovative care. International Journal of Bipolar Disorders, Springer Open, 2013, 1 (1), pp.2. inserm-00814543 HAL Id: inserm-00814543 https://www.hal.inserm.fr/inserm-00814543 Submitted on 17 Apr 2013 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Henry et al. International Journal of Bipolar Disorders 2013, 1:2 http://www.journalbipolardisorders.com/content/1/1/2 REVIEW Open Access European Network of Bipolar Research Expert Centre (ENBREC): a network to foster research and promote innovative care Chantal Henry1,2,3,4*, Ole A Andreassen5, Angelo Barbato6, Jacques Demotes-Mainard7, Guy Goodwin8, Marion Leboyer1,2,3,4, Eduard Vieta9, Willem A Nolen10, Lars Vedel Kessing11, Jan Scott12, Michael Bauer13 and The ENBREC study group14 Abstract Bipolar disorders rank as one of the most disabling illnesses in working age adults worldwide.
    [Show full text]
  • Cognitive Dysfunction in Bipolar Disorder
    Cognitive Dysfunction in Bipolar Disorder A Guide for Clinicians Edited by Joseph F. Goldberg, M.D. Katherine E. Burdick, Ph.D. Washington, DC London, England Note: The authors have worked to ensure that all information in this book is ac- curate at the time of publication and consistent with general psychiatric and med- ical standards, and that information concerning drug dosages, schedules, and routes of administration is accurate at the time of publication and consistent with standards set by the U.S. Food and Drug Administration and the general medical community. As medical research and practice continue to advance, however, ther- apeutic standards may change. Moreover, specific situations may require a specific therapeutic response not included in this book. For these reasons and because hu- man and mechanical errors sometimes occur, we recommend that readers follow the advice of physicians directly involved in their care or the care of a member of their family. Books published by American Psychiatric Publishing, Inc., represent the views and opinions of the individual authors and do not necessarily represent the policies and opinions of APPI or the American Psychiatric Association. If you would like to buy between 25 and 99 copies of this or any other APPI title, you are eligible for a 20% discount; please contact APPI Customer Service at [email protected] or 800-368-5777. If you wish to buy 100 or more copies of the same title, please e-mail us at [email protected] for a price quote. Copyright © 2008 American Psychiatric Publishing, Inc. ALL RIGHTS RESERVED Manufactured in the United States of America on acid-free paper 12 11 10 09 08 5 4 3 2 1 First Edition Typeset in Adobe Galliard and Optima American Psychiatric Publishing, Inc.
    [Show full text]
  • Department of Psychiatry Annual Report 2015 Contents PAGE
    Department of Psychiatry Annual Report 2015 Contents PAGE Introduction – Professor John Geddes 1 Clinical Medicine Undergraduate Course – Dr Jonathan Price 2 Honorary Senior Clinical Lecturers 2014-2015 4 Graduate Studies – Dr Phil Burnet and Dr Jennifer Rendell 5 Post-graduate Medical Training – Professor Klaus Ebmeier 7 RESEARCH REPORTS FROM DEPARTMENTAL PRINCIPAL INVESTIGATORS Dr Matthew Broome: Early Detection and Neuroscience of Psychopathology 9 Dr Phil Burnet: Neurobiology and Experimental Therapeutics 11 Prof Tom Burns: Social Psychiatry 13 Prof Andrea Cipriani: Systematic Review and Meta-Analysis Group 14 Prof Phil Cowen: Psychopharmacology Research Group 16 Prof Klaus Ebmeier: Neurobiology of Ageing 18 Prof Christopher Fairburn and Prof Zafra Cooper: Centre for Research on Dissemination at Oxford (CREDO) 20 Prof Seena Fazel: Risk Factors for Mental Illness and Violent Crime 22 Prof Daniel Freeman: Cognitive Approaches to Psychosis 23 Prof John Geddes: Experimental Epidemiology and Bipolar Disorder 25 Prof Guy Goodwin: Experimental Medicine and Neurobiology of Mood Disorders 27 Prof Catherine Harmer: Psychopharmacology and Emotion Research Laboratory 28 Prof Paul Harrison: Translational Neurobiology of Psychosis 29 Prof Keith Hawton: Centre for Suicide Research 31 Prof Emily Holmes: Experimental Psychopathology and Cognitive Therapies (EPACT) 33 Prof Belinda Lennox: Enhancing Outcomes for Early Psychosis 35 Prof Simon Lovestone: Translational Neuroscience and Dementia Research Group 36 Prof Clare Mackay: Translational Neuroimaging
    [Show full text]
  • Editorial Advisory Committee
    EDITORIAL ADVISORY COMMITTEE Giovanni Berlucchi Mary B. Bunge Robert E. Burke Larry E Cahill Stanley Finger Bernice Grafstein Russell A. Johnson Ronald W. Oppenheim Thomas A. Woolsey (Chairperson) The History of Neuroscience in" Autob~ograp" by VOLUME 5 Edited by Larry R. Squire AMSTERDAM 9BOSTON 9HEIDELBERG 9LONDON NEW YORK 9OXFORD ~ PARIS 9SAN DIEGO SAN FRANCISCO 9SINGAPORE 9SYDNEY 9TOKYO ELSEVIER Academic Press is an imprint of Elsevier Elsevier Academic Press 30 Corporate Drive, Suite 400, Burlington, Massachusetts 01803, USA 525 B Street, Suite 1900, San Diego, California 92101-4495, USA 84 Theobald's Road, London WC1X 8RR, UK This book is printed on acid-free paper. O Copyright 92006 by the Society for Neuroscience. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher. Permissions may be sought directly from Elsevier's Science & Technology Rights Department in Oxford, UK: phone: (+44) 1865 843830, fax: (+44) 1865 853333, E-mail: [email protected]. You may also complete your request on-line via the Elsevier homepage (http://elsevier.com), by selecting "Support & Contact" then "Copyright and Permission" and then "Obtaining Permissions." Library of Congress Catalog Card Number: 2003 111249 British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library ISBN 13:978-0-12-370514-3 ISBN 10:0-12-370514-2 For all information on all Elsevier Academic Press publications visit our Web site at www.books.elsevier.com Printed in the United States of America 06 07 08 09 10 11 9 8 7 6 5 4 3 2 1 Working together to grow libraries in developing countries www.elsevier.com ] ww.bookaid.org ] www.sabre.org ER BOOK AID ,~StbFC" " " =LSEVI lnt .....
    [Show full text]
  • Keynote Lecture Starts Congress with a Bang Neuronal Death Or by Inducing a Greater Proportion of Stem Cells to Reenter Mito- Sis
    3 Thinking ahead: Immunotherapy in the brain 4 Plenary lecture: The official newspaper Paul Harrison discusses of ECNP Congress 2012 a combined approach to schizophrenia therapy Issue 2 6 Blossoming future for mental health with ECNP Monday disruptive innovation 15 October 12 The neural mechanisms of DAILY NEWS gambling are put to the test 2012 Keynote lecture starts congress with a bang neuronal death or by inducing a greater proportion of stem cells to reenter mito- sis. Although this demonstrated that this process could be trivially achieved, it is not sufficient simply to have an increased number of brain cells; they need to be organised in a more sophisticated man- ner as well. Professor Blakemore continued: “How could the enlargement of the brain make it more useful? What kind of processes would the brain have to go through in order to be better, simply as a result of being larger? If you look at the way in which the brain changed during the mammalian evolution by extant species representative of different points in the mammalian line, what we see is that the sensory areas – the audio, visual, somatic sensory areas – maintain their relative positions throughout evolution, but they occupy a relatively smaller pro- portion of the cortex in more advanced species. It’s not simply that the brain has uniformly increased in size, but it is that it has introduced more space in between the primary sensory areas and the motor areas. That has generated space for more Colin Blakemore specialised areas and we now know that the whole of the cerebral cortex is a Continuing with an interesting mosaic of specialised areas.” The Keynote Session on Saturday evening was filled perspective of the evolutionary under- How this was achieved throughout with awards, speeches and live entertainment that pinnings of the growth of the hominid the course of mammalian evolution is served as a befitting tribute to the opening of the brain, Professor Blakemore said: “I difficult to ascertain.
    [Show full text]
  • 2001 Scientific Program Committee
    2001 SCIENTIFIC PROGRAM COMMITTEE Seated (left to right): Drs. McDowell, Ordorica, Butterfield, Muskin, Mega, Shafii. 1* Row Standing (left to right): Dr. Blake, Mrs. Foulks, Drs. Ruiz, Taylor, Judge, Jayaram, Levin, Crone, Goldfinger, Cheong, Casey. 2nd Row Standing (left to right): Drs. Dawkins, D'Alli, Wint, Foulks, Stabinsky, Groves, Cutler, Blinder, Stangler, Alessi, Spitz, Pandya, Dudley. May 5, 2001 Dear Colleagues and Guests: Welcome to the 154th Annual Meeting of the American Psychiatric Association, the first in the new century. The coming week will highlight the best in our profession in the largest psychiatric meeting in the world. Our meeting has become an outstanding international forum to discuss the latest scientific advances and traditional humane values in psychiatry and how we will continue to integrate these bodies of knowledge to provide excellent patient care into the future. This year's Annual Meeting theme is "Mind Meets Brain: Integrating Psychiatry, Psychoanalysis, Neuroscience." Many sessions throughout the week will highlight an important aspect of the theme. Please make a special effort to attend the Monday afternoon Presidential Symposium, from 2:00 p.m.-5:00 p.m., entitled, "The Royal Road Revisited: Dreams in the 21st Century." I join our colleagues from North America in greeting the thousands of colleagues from other parts of the world who have joined us in New Orleans. At the Opening Session, from 5:00 p.m.-6:30 p.m., on Sunday, we will officially welcome the leaders from psychiatric societies in the U.S. and around the world. I will present my Presidential Address, and I look forward to seeing you there.
    [Show full text]
  • Risk for Depression and Neural Responses to Fearful Facial Expressions of Emotion
    Edinburgh Research Explorer Risk for depression and neural responses to fearful facial expressions of emotion Citation for published version: Chan, S, Norbury, R, Goodwin, G & Harmer, C 2009, 'Risk for depression and neural responses to fearful facial expressions of emotion', The British Journal of Psychiatry, vol. 194, no. 2, pp. 139-145. https://doi.org/10.1192/bjp.bp.107.047993 Digital Object Identifier (DOI): 10.1192/bjp.bp.107.047993 Link: Link to publication record in Edinburgh Research Explorer Document Version: Peer reviewed version Published In: The British Journal of Psychiatry Publisher Rights Statement: © Chan, S., Norbury, R., Goodwin, G., & Harmer, C. (2009). Risk for depression and neural responses to fearful facial expressions of emotion. The British Journal of Psychiatry, 194(2), 139-145. General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 29. Sep. 2021 This is the authors’ final version, also known as a postprint. ©Chan, S., Norbury, R., Goodwin, G., & Harmer, 1 C. (2009). Risk for depression and neural responses to fearful facial expressions of emotion.
    [Show full text]